Myocarditis

There are 35 papers on myocarditis in aging research: 17 observational studies in people, 7 in animals, 9 reviews. The newest story, Nov 7, 2026: “Early heart conditions linked to later serious heart problems”.

Disease

35 papers study it26 more mention it7 findings

MeSH

14 new papers in 30 daysSee all 61 papers on myocarditis

“3.65 (95% CI, 1.16-11.49; P = .03) for TET2 with myocarditis.”
Clonal Hematopoiesis and Risk of New-Onset Myocarditis and PericarditisJAMA cardiology2025doi:10.1001/jamacardio.2025.3369
  • Humans17
  • Animals7
  • In silico2

Interventions

1

SGLT2 inhibitors

no changein humans1RR 1.001

1 study
  1. SGLT2 inhibitors were not clearly linked with myocarditis in patients receiving immune checkpoint inhibitors, after propensity score matching (RR 1.001, 95% CI 0.417-2.401).

    “The risk of AMI (RR 0.85, 95% CI: 0.592-1.212, p-value 0.3625) and myocarditis (RR 1.001, 95% CI: 0.417-2.401, p-value 0.998) was similar between both groups.”

    Humansin patients receiving immune checkpoint inhibitors, after propensity score matchingn = 2,862

    Effect Of SGLT2 Inhibitors On Cardiovascular Protection In Patients Undergoing Immune Checkpoint Therapy

    AHA Scientific Sessions 2025 abstract

More on SGLT2 inhibitors

Associations

6

Cannabis use

upin humans1HR 3.48

1 study
  1. Cannabis use is associated with myocarditis in humans (propensity-matched adults) (HR 3.48, 95% CI 2.25–5.38).

    “Both components were independently significant at 3 years: pericarditis (HR 1.81, 1.32-2.48) and myocarditis (HR 3.48, 2.25-5.38).”

    Humanspropensity-matched adults3 years

    Cannabis Use and Risk of Pericarditis and Myocarditis in Young Adults: A Propensity Matched Cohort Study

    AHA Scientific Sessions 2026 abstract

More on Cannabis use

CHIP-associated somatic mutations

upin humans1

1 study
  1. CHIP-associated somatic mutations are associated with myocarditis in humans (advanced heart failure undergoing heart transplantation; prior myocarditis) (3/5 vs 4/99; odds ratio 32.2, p=0.0018).

    “CHIP mutations were enriched in patients with prior myocarditis (3/5 vs 4/99; Fisher’s exact test odds ratio 32.2, p=0.0018)”

    Humansadvanced heart failure undergoing heart transplantation; prior myocarditiscardiac tissue25% womensn = 104

    Somatic DNMT3A and TET2 mutations in explanted hearts from advanced heart failure show enrichment in myocarditis and inflammatory heart disease

    ESC Congress 2026 abstract

More on CHIP-associated somatic mutations

Older age

upin humans1RR 1.27

1 study
  1. Older age is linked with a higher risk of myocarditis in humans (cancer patients initiating ICIs) (RR 1.27; 95% CI 1.05 - 1.53).

    “risks significantly increased for myocarditis (RR 1.27; 95% CI 1.05 - 1.53)”

    Humanscancer patients initiating ICIs

    Differential Toxicity of Immune Checkpoint Inhibitors in Older Adults: A Large-Scale, Propensity Score-Matched Real-World Analysis

    Cancer investigation

Immune checkpoint inhibitors

upin humans1OR 2.64

1 study
  1. Immune checkpoint inhibitors are linked with a higher risk of myocarditis in humans (cancer patients under ICI therapy (2021-2023 vs 2018-2020)) (OR 2.64, 95% CI 1.10-6.36, P = 0.03).

    “Patients enrolled between 2021 and 2023 showed higher incidence of myocarditis (odds ratio [OR]: 2.64; 95% confidence interval [CI]: 1.10-6.36; P = 0.03)”

    Humanscancer patients under ICI therapy (2021-2023 vs 2018-2020)

    Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio-oncology Registry

    British journal of pharmacology

More on Immune checkpoint inhibitors

Sudden cardiac death

upin humans1

1 study
  1. Myocarditis is associated with sudden cardiac death in humans (amateur athletes with recent respiratory infections).

    “followed by atherosclerotic coronary artery disease-particularly in athletes older than 35 years-and myocarditis, mainly in younger individuals with recent respiratory infections.”

    Reviewamateur athletes with recent respiratory infections

    Cardiovascular diseases and risk factors associated with sudden cardiac death in amateur athletes: a scoping review

    Frontiers in public health

More on Sudden cardiac death

TET2

upin humans1HR 3.65

1 study
  1. TET2 is associated with myocarditis in humans (TET2 CHIP) (HR 3.65, 95% CI 1.16-11.49; P = .03).

    “3.65 (95% CI, 1.16-11.49; P = .03) for TET2 with myocarditis.”

    HumansTET2 CHIP

    Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis

    JAMA cardiology

More on TET2

Trial sponsors

Funding

2 grants since 2024

National Institute of Allergy and Infectious Diseases$413KNational Heart, Lung, and Blood Institute$850K

Latest

Dec 2025: 2Jan 2026: 3Feb 2026: 2Mar 2026: 2Apr 2026: 2May 2026: 2Jun 2026: 0Jul 2026: 2Aug 2026: 1Sep 2026: 3Oct 2026: 7Nov 2026: 733 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Early heart conditions linked to later serious heart problems

Heart muscle disease or serious rhythm problems occurred in 11% of people with early warning conditions, compared with 1.8% of controls.Heart muscle disease or serious rhythm problems occurred in 11% of people with early warning conditions, compared with 1.8% of controls.

Cohort · 165,082 peoplePopulations
Journal of Diabetes Science and Technology

Diabetes drugs linked to mixed risks across the body

Among 70,982 adults followed for up to five years, researchers identified 65 lower-risk and 53 higher-risk associations compared with other diabetes drugs.Among 70,982 adults followed for up to five years, researchers identified 65 lower-risk and 53 higher-risk associations compared with other diabetes drugs.

Cohort · 70,982 peopleType 2 diabetes

See all 61 papers on myocarditis